The AIM-HI Beacon Award for Women Leaders in Oncology honors exceptional women leaders across the health and life sciences sectors who have made transformative contributions to advancing cancer treatment, detection, and diagnosis for patients worldwide. The Nomination Deadline for the 2026 AIM-HI Beacon Award is June 30, 2026, at 11:55 PM Eastern time.

The 2026 AIM-HI Beacon Award recipient will be honored with a commemorative medal and invited to deliver a keynote address at the Luncheon Award Ceremony at the National Press Club in Washington DC on October 9, 2026.

All nomination materials will be treated as strictly confidential and reviewed by the distinguished AIM-HI Beacon Award Selection Committee, composed of leading cancer researchers and clinicians, accomplished entrepreneurs, and prominent industry and business leaders in the health and life sciences.

Nominations will be evaluated based on the following criteria:

• Sustained leadership and commitment to advancing the oncology community
• Advocacy for policies and initiatives that benefit cancer patients
• Commitment to mentoring and inspiring women, particularly the next generation of leaders
• Demonstrated impact on cancer patients, their families, and the broader community